0001209191-20-012285.txt : 20200224
0001209191-20-012285.hdr.sgml : 20200224
20200224200214
ACCESSION NUMBER: 0001209191-20-012285
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200216
FILED AS OF DATE: 20200224
DATE AS OF CHANGE: 20200224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRYANT DOUGLAS C
CENTRAL INDEX KEY: 0001406652
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 20646820
MAIL ADDRESS:
STREET 1: C/O QUIDEL CORPORATION
STREET 2: 12544 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2020-02-16
2020-02-19
0
0000353569
QUIDEL CORP /DE/
QDEL
0001406652
BRYANT DOUGLAS C
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
Common Stock
2020-02-16
4
F
0
8198
80.40
D
440823
D
On February 19, 2020, the Reporting Person filed a Form 4 which reported the disposition of 8,606 shares in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon the release of restricted stock units. Due to a clerical error, the number of shares reported as withheld was incorrectly calculated and reported. The correct amount of shares withheld was 8,198.
Robert J. Bujarski, attorney-in-fact for Douglas C. Bryant
2020-02-24